Riboflavin and Vitamin B6: study protocols
25 study groups took Riboflavin together with Vitamin B6. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Riboflavin
25 study groups in 21 studies say how much Riboflavin participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg, 40% of 25 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mg or less | 1 |
| 1 mg to 2.5 mg | 10 |
| 2.5 mg to 5 mg | 8 |
| 5 mg to 10 mg | 3 |
| 10 mg to 25 mg | 2 |
| over 25 mg | 1 |
Dose per serving from research: Vitamin B6
25 study groups in 21 studies say how much Vitamin B6 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg, 28% of 25 study groups.
| Daily dose | Study groups |
|---|---|
| 500 mcg or less | 1 |
| 500 mcg to 1 mg | 2 |
| 1 mg to 2.5 mg | 7 |
| 2.5 mg to 5 mg | 5 |
| 5 mg to 10 mg | 3 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 5 |
Commonly used together
25 of 25 study groups took Riboflavin and Vitamin B6 with something else. Shown: what 3 or more different studies gave. The 10 most common of 15.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin B12 | 23 |
| Folic Acid | 18 |
| Thiamine | 14 |
| Vitamin E | 10 |
| Vitamin D | 9 |
| Zinc | 9 |
| Iron | 8 |
| Vitamin C | 8 |
| Vitamin A | 7 |
| Copper | 5 |
25 study groups
| Study | ||||
|---|---|---|---|---|
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 1.6 mg | 1.7 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 1.8 mg | 2.2 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 20 mg | 25 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women | 20 mg | 25 mg | — | — |
| Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial 2015 · Verum (investigational nutritional product) · Adults aged 18–65 of either sex with migraine with or without aura, and at least 3 migraine attacks per month before recruitment | 400 mg | 5 mg | 90 days | 63 |
| Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction 1992 · active vitamin group · Geriatric inpatients with depression and cognitive dysfunction | 10 mg | 10 mg | 4 weeks | — |
| Effect of zinc plus multivitamin supplementation on growth in school children 2016 · Chelated zinc plus multivitamins · Healthy Thai schoolchildren aged 4–13 years | 3 mg | 1 mg | 26 weeks | 70 |
| A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial 2023 · Ex PLUS® group · Healthy male and female non-athletes aged 20–30 | 10 mg | 50 mg | 4 weeks | 32 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 10 mg | 10 mg | 120 days | — |
| Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance 2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking | 1.1 mg | 730 mcg | 90 days | — |
| A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status 2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening | 5 mg | 10 mg | 2 years | 103 |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception | 1.8 mg | 2.6 mg | — | 870 |
| Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial 2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies | 500 mcg | 500 mcg | 36 weeks | 130 |
| A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels 2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified | 3.98 mg | 3.38 mg | 6 weeks | 30 |
| A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels 2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified | 3.98 mg | 3.38 mg | 6 weeks | 30 |
| B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke 2004 · B-group vitamin supplements · Patients with acute ischaemic stroke, enrolled within 12 hours of symptom onset; age and sex not specified | 5 mg | 50 mg | 2 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 5 mg | 50 mg | 2 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 5 mg | 50 mg | 2 weeks | 24 |
| Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial 2016 · Fortified cereal, morning · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness | 1.71 mg | 1.74 mg | 12 weeks | 18 |
| Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial 2016 · Fortified cereal, evening · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness | 1.71 mg | 1.74 mg | 12 weeks | 16 |
| Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete 2001 · Vitamin B-6 supplementation group · Healthy adults aged 63–80 years; folate- and riboflavin-replete, with no vitamin B-12 deficiency | 1.6 mg | 1.6 mg | 12 weeks | — |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 1.4 mg | 1.9 mg | 12 weeks | 105 |
| Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial 2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male | 2.4 mg | 3 mg | 60 days | 52 |
| Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour 2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women | 5 mg | 50 mg | 12 weeks | — |
| Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial 2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated | 1.3 mg | 1.4 mg | 6 weeks | — |